시장보고서
상품코드
1733946

세계의 이식형 루프 레코더 시장

Implantable Loop Recorders

발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 376 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

이식형 루프 레코더 세계 시장은 2030년까지 26억 달러에 달할 전망

2024년에 15억 달러로 추정되는 이식형 루프 레코더 세계 시장은 2024년부터 2030년까지 CAGR 9.0%로 성장하여 2030년에는 26억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석하고 있는 부문 중 하나인 수동 이식형 루프 레코더는 CAGR 10.3%를 기록하며 분석 기간 종료시에는 17억 달러에 달할 것으로 예측됩니다. 자동 이식형 루프 레코더 분야의 성장률은 분석 기간 동안 CAGR 6.9%로 추정됩니다.

미국 시장은 추정 4억 1,730만 달러, 중국은 CAGR 14.2%로 성장 예측

미국의 이식형 루프 레코더 시장은 2024년에 4억 1,730만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 14.2%로 2030년까지 5억 7,200만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 4.5%와 8.7%로 예측됩니다. 유럽에서는 독일이 CAGR 약 6.1%로 성장할 것으로 예측됩니다.

세계의 이식형 루프 레코더 시장 - 주요 동향과 촉진요인 정리

현대 심장병학에서 임플란트 루프 레코더의 임상적 관련성을 촉진하는 요인은 무엇인가?

삽입형 심장 모니터(ICM)로도 알려진 이식형 루프 레코더(ILR)는 최대 3년 동안 지속적으로 ECG를 모니터링할 수 있어 장기적인 심장 리듬 모니터링에 혁명을 일으켰습니다. 이 피하 장치는 원인 불명의 실신, 원인 불명의 뇌졸중, 발작성 심방세동과 같은 간헐적 부정맥의 진단에 특히 유용합니다. 기존의 홀터 모니터나 외부 이벤트 기록 장치와 달리, ILR은 단기간의 데이터 수집과 전극을 착용해야 하는 환자의 순응도 위반에 대한 제한을 없앴습니다. 무증상 환자도 중단 없이 심장을 모니터링할 수 있기 때문에 특히 부정맥 에피소드가 드물거나 예측할 수 없는 경우, 진단 결과가 크게 향상됩니다.

미국심장학회(AHA)와 유럽심장학회(ESC)의 임상 가이드라인에서 원인불명의 실신이나 일시적 의식소실 환자에게 ILR을 1차 선택 수단으로 권장하는 경우가 증가하고 있어, 심장 진단 경로에서 ILR의 위치는 더욱 정당성을 얻고 있습니다. 실신뿐만 아니라 뇌졸중 후 원인 불명의 평가에서도 미검출 심방세동이 기저 요인이 될 수 있는 경우 ILR의 사용이 증가하고 있습니다. 또한, 유전성 부정맥 증후군 환자의 장기 모니터링과 심방세동 절제술 후 심방세동 재발에 대한 모니터링에도 중요한 역할을 하고 있으며, 일반 심장내과와 전기생리학의 하위 전문 분야 모두에서 그 유용성이 확대되고 있습니다.

기술의 발전은 임베디드 루프 레코더의 상황을 어떻게 변화시키고 있는가?

최근 몇 년 동안 ILR의 설계와 데이터 처리 능력에 있어 급속한 기술 혁신이 일어나고 있습니다. 새로운 세대의 장비는 소형화되어 외래에서 최소침습적으로 삽입할 수 있는 시술이 용이해졌습니다. 예를 들어, 현재 일부 장치는 부피가 1 입방 센티미터 미만이며, 5분 이내에 이식할 수 있습니다. 이러한 소형화된 폼팩터는 환자의 편안함을 향상시킬 뿐만 아니라 시술의 위험과 의료 시스템의 비용 부담을 줄여줍니다. 배터리 수명도 크게 개선되어 현재 대부분의 기기는 교체 없이 3-4년 동안 사용할 수 있습니다.

디지털 측면에서는 원격 원격 측정 시스템 및 스마트폰용 환자 앱과의 통합을 통해 실시간 데이터 액세스 및 임상 워크플로우를 획기적으로 개선했습니다. 의사는 심수축, 서맥, 심방세동과 같은 중요한 이벤트에 대한 즉각적인 알림을 받을 수 있게 되어 보다 빠른 개입이 가능해졌습니다. 이와 함께 인공지능과 머신러닝 알고리즘이 클라우드 기반 플랫폼에 통합되어 오탐을 줄이고 대규모 데이터세트의 패턴 인식을 자동화하고 있습니다. 이러한 기능은 원격 환자 모니터링 프로그램, 원격 심장학 서비스, 전통적인 임상 환경 외의 만성질환 집단 관리에 특히 유용합니다.

채용의 핫스팟과 확대되는 임상 응용 분야는?

북미와 유럽은 보험 상환 정책, 강력한 임상 인프라, 원격 모니터링 기술의 조기 통합으로 인해 현재 전 세계 ILR 채택을 주도하고 있습니다. 그러나 아시아태평양 및 라틴아메리카의 신흥 시장에서는 심장 진단에 대한 접근성 향상, 심방세동과 관련된 뇌졸중에 대한 인식 증가, 심장 건강에 대한 공공 투자 증가로 인해 임플란트 설치가 증가하고 있습니다. 정부와 보험사들도 ILR의 비용 대비 효과가 입원 재입원 및 뇌졸중 관련 장애를 줄이는 데 도움이 된다는 것을 인식하기 시작했습니다.

임상적 사용과 관련하여 실신 진단이 여전히 주요 적응증이지만, ILR은 뇌졸중의 이차 예방 프로그램에서 빠르게 확산되고 있습니다. 많은 뇌졸중 센터에서 ILR을 진단에 통합하여 색전성 뇌졸중의 흔한 원인이지만 잘 진단되지 않는 잠복성 발작성 심방세동을 감지하기 위해 ILR을 진단에 통합하고 있습니다. 또한, 전기생리학적 검사에서 절제술 후 감시, 특히 심박조율기나 CRT와 같은 심장 장치를 이식한 환자의 구조적 심장병 관리에서도 ILR의 역할이 확대되고 있으며, 보조적인 진단적 인사이트를 얻을 수 있습니다. 소아심장학은 또 다른 분야로, ILR은 해부학적 및 시술적 고려사항으로 인해 신중한 선택 기준이 필요하지만, 젊은 연령층에서 유전성 리듬 장애의 평가에 관심을 끌고 있습니다.

임베디드 루프 레코더 시장의 성장 원동력은 몇 가지 요인에 기인합니다.

첫째, 장비의 소형화와 최소침습적 삽입술에 대한 끊임없는 기술 혁신으로 인해 고소득 국가와 중산층 국가 모두에서 도입 문턱이 크게 낮아졌습니다. 이는 외래 및 지역 기반 심장 치료 모델에서 사용할 수 있는 새로운 길을 열었습니다. 둘째, 원격 모니터링 기술과 클라우드 기반 분석 플랫폼의 통합으로 ILR은 커넥티드 헬스 도구가 되어 디지털 헬스, 분산형 케어, 원격 모니터링으로 전환하는 세계 트렌드에 잘 부합하는 도구가 되었습니다. 이러한 발전을 통해 순환기 전문의는 진단의 정확성을 유지하면서 더 많은 환자군을 효율적으로 관리할 수 있게 되었습니다.

셋째, 뇌경색 진단, 심방세동 모니터링, 심방세동 절제술 후 모니터링, 유전성 리듬 장애 감지 등 임상 사용 사례의 확대로 인해 대응할 수 있는 환자 수가 증가하고 있습니다. 또한, 미국, 독일, 일본 등 주요 시장에서의 지원적인 급여 정책은 의사의 도입과 환자 접근을 촉진하는 데 있어 매우 중요합니다. 넷째, 전 세계적으로 심방세동과 뇌졸중을 중심으로 한 심혈관계 질환의 증가로 인해 조기에 신뢰할 수 있는 리듬 진단에 대한 필요성이 증가하고 있으며, 이는 ILR에 대한 지속적인 수요를 창출하고 있습니다. 마지막으로, 인지도 향상, 심장학 인프라 개선, 주요 기기 제조업체의 타겟팅된 판매 전략으로 인해 신흥 지역에서 이러한 기기의 가용성이 증가함에 따라 시장 성장을 촉진하고 있습니다.

부문

제품(수동 제품, 자동 제품), 적응증(심혈관계 실신 적응증, 뇌졸중 적응증, 심부전 적응증, 심장 부정맥 적응증, 심방세동 적응증, 각차단 적응증, 기타 적응증), 최종사용자(병원 최종사용자, 심장 센터 및 클리닉 최종사용자, 외래 수술 센터 최종사용자)

조사 대상 기업 사례(총 34개사)

  • Abbott Laboratories
  • Angel Medical Systems, Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Insight, Inc.
  • Cardiovascular Systems, Inc.
  • ConMed Corporation
  • Cook Medical
  • GE Healthcare
  • HeartWare International, Inc.
  • Hill-Rom Holdings, Inc.
  • iRhythm Technologies, Inc.
  • Koninklijke Philips N.V.
  • LifeWatch Technologies
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Philips Healthcare
  • Preventice Solutions
  • ProgenyHealth

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 인위적인 매출원가 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

Global Industry Analysts는 세계 주요 수석 이코노미스트(1,4,949명), 싱크탱크(62개 기관), 무역 및 산업 단체(171개 기관)의 전문가들의 의견을 면밀히 검토하여 생태계에 미치는 영향을 평가하고 새로운 시장 현실에 대응하고 있습니다. 모든 주요 국가의 전문가와 경제학자들이 관세와 그것이 자국에 미치는 영향에 대한 의견을 추적 조사하고 있습니다.

Global Industry Analysts는 이러한 혼란이 향후 2-3개월 내에 마무리되고 새로운 세계 질서가 보다 명확하게 확립될 것으로 예상하고 있으며, Global Industry Analysts는 이러한 상황을 실시간으로 추적하고 있습니다.

2025년 4월 : 협상 단계

이번 4월 보고서에서는 관세가 세계 시장 전체에 미치는 영향과 지역별 시장 조정에 대해 소개합니다. 당사의 예측은 과거 데이터와 진화하는 시장 영향요인을 기반으로 합니다.

2025년 7월 : 최종 관세 재설정

고객님들께는 각 국가별 최종 리셋이 발표된 후 7월에 무료 업데이트 버전을 제공해 드립니다. 최종 업데이트 버전에는 명확하게 정의된 관세 영향 분석이 포함되어 있습니다.

상호 및 양자 간 무역과 관세의 영향 분석:

미국 <>중국 <>멕시코 <>캐나다 <>EU <>일본 <>인도 <>기타 176개국

업계 최고의 이코노미스트 : Global Industry Analysts의 지식 기반은 국가, 싱크탱크, 무역 및 산업 단체, 대기업, 그리고 세계 계량 경제 상황의 전례 없는 패러다임 전환의 영향을 공유하는 분야별 전문가 등 가장 영향력 있는 수석 이코노미스트 그룹을 포함한 14,949명의 이코노미스트를 추적하고 있습니다. 16,491개 이상의 보고서 대부분에 마일스톤에 기반한 2단계 출시 일정이 적용되어 있습니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.06.13

Global Implantable Loop Recorders Market to Reach US$2.6 Billion by 2030

The global market for Implantable Loop Recorders estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.6 Billion by 2030, growing at a CAGR of 9.0% over the analysis period 2024-2030. Manual Implantable Loop Recorders, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Automatic Implantable Loop Recorders segment is estimated at 6.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$417.3 Million While China is Forecast to Grow at 14.2% CAGR

The Implantable Loop Recorders market in the U.S. is estimated at US$417.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$572.0 Million by the year 2030 trailing a CAGR of 14.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 8.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Global Implantable Loop Recorders Market - Key Trends & Drivers Summarized

What Is Driving the Clinical Relevance of Implantable Loop Recorders in Modern Cardiology?

Implantable loop recorders (ILRs), also known as insertable cardiac monitors (ICMs), have revolutionized long-term cardiac rhythm monitoring by enabling continuous ECG surveillance for up to three years. These subcutaneous devices are particularly valuable in diagnosing unexplained syncope, cryptogenic stroke, and intermittent arrhythmias, such as paroxysmal atrial fibrillation. Unlike traditional Holter monitors or external event recorders, ILRs eliminate the limitations of short-term data capture and patient non-compliance with wearable electrodes. This ability to provide uninterrupted cardiac monitoring, even in asymptomatic patients, significantly enhances diagnostic yield, especially in cases where arrhythmic episodes are infrequent or unpredictable.

Clinical guidelines from the American Heart Association (AHA) and European Society of Cardiology (ESC) increasingly recommend ILRs as first-line tools in patients with unexplained syncope or transient loss of consciousness, further legitimizing their place in cardiac diagnostic pathways. Beyond syncope, there is growing utilization of ILRs in post-stroke evaluation for cryptogenic causes, where undetected atrial fibrillation may be an underlying factor. These devices are also proving critical in long-term monitoring for patients with inherited arrhythmia syndromes or post-ablation monitoring for recurrence of atrial fibrillation, expanding their utility in both general cardiology and electrophysiology subspecialties.

How Are Technology Advancements Reshaping the Implantable Loop Recorder Landscape?

The past few years have witnessed rapid innovation in ILR design and data handling capabilities. New-generation devices are increasingly miniaturized, facilitating minimally invasive insertion procedures that can be performed in outpatient settings. For instance, some devices now measure less than 1 cubic centimeter in volume and can be implanted in under five minutes. These miniaturized form factors not only improve patient comfort but also reduce procedural risk and cost burden on healthcare systems. Battery longevity has also improved significantly, with most devices now lasting between three and four years without replacement.

On the digital front, integration with remote telemetry systems and smartphone-compatible patient apps has dramatically improved real-time data access and clinical workflow. Physicians can now receive instant alerts for critical events such as asystole, bradycardia, or atrial fibrillation episodes, enabling earlier interventions. In parallel, artificial intelligence and machine learning algorithms are being embedded into cloud-based platforms to reduce false positives and automate pattern recognition across large datasets. These capabilities are especially beneficial in remote patient monitoring programs, telecardiology services, and in managing chronic disease populations outside traditional clinical settings.

Where Are the Adoption Hotspots and Which Clinical Applications Are Expanding?

North America and Europe currently lead global ILR adoption, driven by well-established reimbursement policies, strong clinical infrastructure, and early integration of remote monitoring technologies. However, emerging markets in Asia-Pacific and Latin America are witnessing a rise in implant volumes due to improved access to cardiac diagnostics, rising awareness of atrial fibrillation-related stroke, and increased investment in public cardiac health initiatives. Governments and insurers are also starting to recognize the cost-effectiveness of ILRs in reducing recurrent hospitalizations and stroke-related disability.

In terms of clinical use, while syncope diagnosis remains the leading indication, ILRs are seeing rapid uptake in secondary stroke prevention programs. Many stroke centers are incorporating ILRs into their diagnostic workup to detect occult paroxysmal atrial fibrillation-a common but underdiagnosed cause of embolic strokes. Furthermore, their role is expanding in electrophysiology for post-ablation surveillance and in structural heart disease management, particularly among patients with implanted cardiac devices like pacemakers or CRTs, where ILRs provide adjunctive diagnostic insights. Pediatric cardiology is another frontier, where ILRs are gaining interest for evaluating inherited rhythm disorders in younger populations, albeit with careful selection criteria due to anatomical and procedural considerations.

The Growth in the Implantable Loop Recorders Market Is Driven by Several Factors…

First, continuous innovation in device miniaturization and minimally invasive insertion techniques has significantly lowered the threshold for adoption across both high- and middle-income countries. This has opened new avenues for use in ambulatory and community-based cardiac care models. Second, the integration of remote monitoring technologies and cloud-based analytics platforms has turned ILRs into connected health tools, aligning well with the global shift toward digital health, decentralized care, and telemonitoring. These advancements allow cardiologists to efficiently manage larger patient cohorts while maintaining diagnostic precision.

Third, the expanding clinical use cases-particularly in cryptogenic stroke diagnostics, atrial fibrillation surveillance, post-ablation monitoring, and inherited rhythm disorder detection-are collectively enlarging the addressable patient pool. Additionally, supportive reimbursement policies in key markets such as the U.S., Germany, and Japan have been critical in driving both physician adoption and patient access. Fourth, rising global cardiovascular disease prevalence, especially atrial fibrillation and stroke, is fueling the need for early and reliable rhythm diagnostics, creating sustained demand for ILRs. Finally, market growth is also bolstered by the increasing availability of these devices in emerging regions, thanks to growing awareness, improving cardiology infrastructure, and targeted distribution strategies by leading device manufacturers.

SCOPE OF STUDY:

The report analyzes the Implantable Loop Recorders market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Manual Product, Automatic Product); Indication (Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication, Other Indications); End-User (Hospitals End-User, Cardiac Centers & Clinics End-User, Ambulatory Surgery Centers End-User)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Angel Medical Systems, Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Insight, Inc.
  • Cardiovascular Systems, Inc.
  • ConMed Corporation
  • Cook Medical
  • GE Healthcare
  • HeartWare International, Inc.
  • Hill-Rom Holdings, Inc.
  • iRhythm Technologies, Inc.
  • Koninklijke Philips N.V.
  • LifeWatch Technologies
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Philips Healthcare
  • Preventice Solutions
  • ProgenyHealth

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Implantable Loop Recorders - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Atrial Fibrillation and Unexplained Syncope Spurs Demand for Continuous Cardiac Monitoring
    • Growing Emphasis on Early Diagnosis of Cardiac Arrhythmias Propels Adoption of Implantable Loop Recorders
    • Increasing Geriatric Population Base Strengthens Business Case for Long-Term Cardiac Monitoring Solutions
    • Technological Advancements in Miniaturization and Battery Life Extend Device Usability and Drive Market Expansion
    • Integration of Remote Monitoring Capabilities Enhances Care Continuity and Accelerates Demand for Smart ILRs
    • Rising Use of AI and Predictive Analytics in Cardiac Monitoring Expands the Value Proposition of ILR Devices
    • Expansion of Outpatient Cardiac Monitoring Programs Throws the Spotlight on Cost-Effective ILR Solutions
    • Increasing Cardiac Monitoring Adoption Across Emerging Economies Expands Global Addressable Market Opportunity
    • Shift Toward Minimally Invasive and Ambulatory Monitoring Procedures Drives Preference for ILRs Over Holter Monitors
    • Growing Investments in Cardiac Telehealth Infrastructure Sustain Growth Momentum in Remote ILR Services
    • Rising Clinical Use of ILRs in Unexplained Strokes Expands Indications and Supports Market Growth
    • Growing Role of Digital Health Ecosystems Facilitates Seamless Data Integration and Boosts Adoption Rates
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Implantable Loop Recorders Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Implantable Loop Recorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Manual Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Manual Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Manual Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Automatic Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Automatic Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Automatic Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Cardiac Centers & Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Cardiac Centers & Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Cardiac Centers & Clinics End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Ambulatory Surgery Centers End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiovascular Syncope Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cardiovascular Syncope Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Cardiovascular Syncope Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Stroke Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Stroke Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Stroke Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Heart Failure Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Heart Failure Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Heart Failure Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Cardiac Arrhythmia Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Cardiac Arrhythmia Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Cardiac Arrhythmia Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Atrial Fibrillation Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Atrial Fibrillation Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Atrial Fibrillation Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Bundle Branch Block Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Bundle Branch Block Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Bundle Branch Block Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • JAPAN
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • CHINA
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • EUROPE
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Implantable Loop Recorders by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • FRANCE
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • GERMANY
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Implantable Loop Recorders by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • INDIA
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Implantable Loop Recorders by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Implantable Loop Recorders by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
  • AFRICA
    • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제